← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

IBEX logoIBEX Limited(IBEX)Earnings, Financials & Key Ratios

IBEX•NASDAQ
$28.11
$379M mkt cap·11.9× P/E·Price updated May 6, 2026
SectorTechnologyIndustryIT ServicesSub-IndustryCustomer Experience Outsourcing and BPO
AboutIBEX Limited provides end-to-end technology-enabled customer lifecycle experience solutions in the United States and internationally. The company provides ibex Connect, a customer engagement solution that comprises customer service, technical support, revenue generation, and other value-added outsourced back-office services through the CX model, which integrates voice, email, chat, SMS, social media, and other communication applications; ibex Digital, a customer acquisition solution that includes digital marketing, e-commerce technology, and platform solutions; and ibex CX, a customer experience solution, which provides a suite of proprietary software tools to measure, monitor, and manage its clients' customer experience. As of October 1, 2021, the company operated 33 customer engagement and three customer acquisition delivery centers. It serves banking and financial services, delivery and logistics, health tech and wellness, high tech, retail and e-commerce, streaming and entertainment, travel and hospitality, and utility industries. The company was formerly known as IBEX Holdings Limited and changed its name to IBEX Limited in September 2019. The company was incorporated in 2017 and is headquartered in Washington, District of Columbia. IBEX Limited is a subsidiary of The Resource Group International Limited.Show more
  • Revenue$558M+9.8%
  • EBITDA$64M+8.4%
  • Net Income$37M+9.5%
  • EPS (Diluted)2.36+28.3%
  • Gross Margin30.91%+3.4%
  • EBITDA Margin11.44%-1.2%
  • Operating Margin8.35%+7.7%
  • Net Margin6.6%-0.2%
  • ROE24.57%+15.2%
  • ROIC19.49%+12.5%
  • Debt/Equity0.52+28.5%
  • Interest Coverage29.11-63.9%
Technical→

IBEX Key Insights

IBEX Limited (IBEX) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Excellent 3Y average ROE of 23.3%
  • ✓Strong 5Y profit CAGR of 36.5%
  • ✓Strong Piotroski F-Score: 7/9
  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Share count reduced 13.9% through buybacks
  • ✓Efficient asset utilization: 2.0x turnover

✗Weaknesses

  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

IBEX Price & Volume

IBEX Limited (IBEX) stock price & volume — 10-year historical chart

Loading chart...

IBEX Growth Metrics

IBEX Limited (IBEX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years6.62%
3 Years4.24%
TTM17.04%

Profit CAGR

10 Years-
5 Years36.53%
3 Years19.77%
TTM27.13%

EPS CAGR

10 Years-
5 Years39.92%
3 Years27.08%
TTM39.74%

Return on Capital

10 Years9.78%
5 Years16.83%
3 Years19.88%
Last Year22.4%

IBEX Recent Earnings

IBEX Limited (IBEX) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 10/12 qtrs (83%)●Beat Revenue 10/12 qtrs (83%)
Q1 2026Latest
Feb 5, 2026
EPS
$0.87
Est $0.79
+10.8%
Revenue
$164M
Est $157M
+4.6%
Q4 2025
Nov 6, 2025
EPS
$0.90
Est $0.81
+11.1%
Revenue
$151M
Est $156M
-2.8%
Q4 2025
Sep 11, 2025
EPS
$0.87
Est $0.73
+18.4%
Revenue
$147M
Est $145M
+1.7%
Q2 2025
May 8, 2025
EPS
$0.82
Est $0.73
+12.3%
Revenue
$141M
Est $133M
+5.9%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q1 2026LatestFeb 5, 2026
$0.87vs $0.79+10.8%
$164Mvs $157M+4.6%
Q4 2025Nov 6, 2025
$0.90vs $0.81+11.1%
$151Mvs $156M-2.8%
Q4 2025Sep 11, 2025
$0.87vs $0.73+18.4%
$147Mvs $145M+1.7%
Q2 2025May 8, 2025
$0.82vs $0.73+12.3%
$141Mvs $133M+5.9%
Based on last 12 quarters of dataView full earnings history →

IBEX Peer Comparison

IBEX Limited (IBEX) competitors in Customer Experience Outsourcing and BPO — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
TTEC logoTTECTTEC Holdings, Inc.Direct Competitor144.71M2.98-0.75-3.2%-9.01%-147.21%7.65
CNXC logoCNXCConcentrix CorporationDirect Competitor1.67B23.72-1.172.15%-13.02%-33.22%1.69
TASK logoTASKTaskUs, Inc.Direct Competitor601.36M6.686.0718.95%11.64%21.23%0.50
TLYS logoTLYSTilly's, Inc.Direct Competitor127.69M4.24-7.31-2.79%-3.15%-21.26%2.00
EPAM logoEPAMEPAM Systems, Inc.Product Competitor5.91B107.0013.650.8%7.01%9.97%0.04
CTSH logoCTSHCognizant Technology Solutions CorporationProduct Competitor24.32B51.3311.286.95%10.41%14.79%0.10
PEGA logoPEGAPegasystems Inc.Product Competitor6.15B36.3717.0816.61%20.04%50.21%0.10
CRM logoCRMSalesforce, Inc.Supply Chain174.3B181.1923.239.58%17.96%12.61%0.11

Compare IBEX vs Peers

IBEX Limited (IBEX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs TTEC

Most directly comparable listed peer for IBEX.

Scale Benchmark

vs CRM

Larger-name benchmark to compare IBEX against a more recognizable public peer.

Peer Set

Compare Top 5

vs TTEC, CNXC, TASK, TLYS

IBEX Income Statement

IBEX Limited (IBEX) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemJun'17Jun'18Jun'19Jun'20Jun'21Jun'22Jun'23Jun'24Jun'25TTM
Sales/Revenue334.03M342.2M368.38M405.13M443.39M492.85M523.12M508.57M558.27M626.95M
Revenue Growth %3.41%2.44%7.65%9.98%9.44%11.16%6.14%-2.78%9.77%17.04%
Cost of Goods Sold276.19M252.93M254.59M276.25M335.25M373.97M374.99M356.54M385.69M328.83M
COGS % of Revenue82.68%73.91%69.11%68.19%75.61%75.88%71.68%70.11%69.09%-
Gross Profit
57.84M▲ 0%
89.28M▲ 54.3%
113.79M▲ 27.5%
128.88M▲ 13.3%
108.14M▼ 16.1%
118.88M▲ 9.9%
148.13M▲ 24.6%
152.03M▲ 2.6%
172.58M▲ 13.5%
133.71M▲ 0%
Gross Margin %17.32%26.09%30.89%31.81%24.39%24.12%28.32%29.89%30.91%21.33%
Gross Profit Growth %-7.35%54.35%27.46%13.26%-16.09%9.93%24.6%2.64%13.52%-
Operating Expenses335.07M363.3M361.34M109.37M91.09M98.25M107.65M112.6M125.97M240.71M
OpEx % of Revenue100.31%106.17%98.09%27%20.54%19.94%20.58%22.14%22.56%-
Selling, General & Admin306.12M332.93M321.72M350.42M080.15M88.66M93.14M108.74M111.3M
SG&A % of Revenue91.64%97.29%87.33%86.5%-16.26%16.95%18.31%19.48%-
Research & Development0000000000
R&D % of Revenue----------
Other Operating Expenses28.96M30.37M39.61M-241.06M91.09M18.1M18.98M19.46M17.23M3M
Operating Income
-2.33M▲ 0%
-17.78M▼ 664.6%
6.8M▲ 138.3%
19.51M▲ 186.7%
17.05M▼ 12.6%
20.63M▲ 21.0%
40.48M▲ 96.3%
39.43M▼ 2.6%
46.61M▲ 18.2%
57.4M▲ 0%
Operating Margin %-0.7%-5.19%1.85%4.82%3.84%4.18%7.74%7.75%8.35%9.16%
Operating Income Growth %-127.15%-664.6%138.28%186.75%-12.65%21%96.26%-2.59%18.21%-
EBITDA11.51M-5.59M27.7M43.98M31.16M38.73M59.46M58.89M63.84M75.95M
EBITDA Margin %3.44%-1.64%7.52%10.86%7.03%7.86%11.37%11.58%11.44%12.11%
EBITDA Growth %-45.77%-148.62%595.08%58.79%-29.15%24.27%53.55%-0.96%8.41%17.19%
D&A (Non-Cash Add-back)13.83M12.18M20.89M24.47M14.12M18.1M18.98M19.46M17.23M18.55M
EBIT-3.44M-18.91M6.8M19M17.05M20.67M41.12M41.5M47.57M41.37M
Net Interest Income-6.39M-3.09M-7.71M-9.43M-9.03M-1.25M-152K1.56M-679K-795K
Interest Income007.25M0043K640K2.07M955K180K
Interest Expense5.28M1.96M7.25M9.43M9.03M1.29M792K514K1.63M664K
Other Income/Expense-6.39M-3.09M-7.71M-9.43M-1.89M-1.25M-152K1.56M-679K-982K
Pretax Income
-8.72M▲ 0%
-20.87M▼ 139.4%
-904K▲ 95.7%
10.09M▲ 1215.6%
15.15M▲ 50.3%
19.38M▲ 27.9%
40.33M▲ 108.1%
40.99M▲ 1.6%
45.93M▲ 12.1%
56.42M▲ 0%
Pretax Margin %-2.61%-6.1%-0.25%2.49%3.42%3.93%7.71%8.06%8.23%9%
Income Tax295K-108K3.62M2.31M2.06M-2.08M8.74M7.33M9.07M3.95M
Effective Tax Rate %-3.38%0.52%-399.89%22.95%13.62%-10.72%21.68%17.89%19.74%7.01%
Net Income
-9.01M▲ 0%
-15.88M▼ 76.2%
-4.52M▲ 71.5%
7.77M▲ 271.9%
13.09M▲ 68.5%
21.46M▲ 63.9%
31.58M▲ 47.2%
33.66M▲ 6.6%
36.86M▲ 9.5%
47.18M▲ 0%
Net Margin %-2.7%-4.64%-1.23%1.92%2.95%4.35%6.04%6.62%6.6%7.53%
Net Income Growth %-673.71%-76.2%71.54%271.94%68.46%63.92%47.19%6.56%9.54%27.13%
Net Income (Continuing)-9.01M-20.76M-4.52M7.77M13.09M21.46M31.58M33.66M36.86M47.18M
Discontinued Operations04.88M15.48M0000000
Minority Interest20M20M00000000
EPS (Diluted)
-0.51▲ 0%
-0.90▼ 76.5%
-0.26▲ 71.1%
0.44▲ 269.2%
0.15▼ 65.9%
1.15▲ 666.7%
1.67▲ 45.2%
1.84▲ 10.2%
2.36▲ 28.3%
3.15▲ 0%
EPS Growth %-674.32%-76.47%71.11%269.23%-65.91%666.67%45.22%10.18%28.26%39.74%
EPS (Basic)-0.51-0.90-0.260.440.161.181.741.902.51-
Diluted Shares Outstanding17.69M17.69M17.69M17.69M18.38M18.72M18.89M18.25M15.72M14.99M
Basic Shares Outstanding17.69M17.69M17.69M17.69M17.65M18.23M18.2M17.7M14.68M13.45M
Dividend Payout Ratio----------

IBEX Balance Sheet

IBEX Limited (IBEX) balance sheet — assets, liabilities & shareholders' equity

Line itemJun'17Jun'18Jun'19Jun'20Jun'21Jun'22Jun'23Jun'24Jun'25TTM
Total Current Assets88.58M82M81.78M86.04M141.37M142.35M158.61M179.96M145.62M165.43M
Cash & Short-Term Investments21.32M13.52M8.87M21.87M57.84M48.83M57.43M62.72M15.35M15.41M
Cash Only21.32M13.52M8.87M21.87M57.84M48.83M57.43M62.72M15.35M15.41M
Short-Term Investments0000000000
Accounts Receivable63.85M60.35M64.12M57.94M72.61M75.43M92.37M107.64M118.7M129.15M
Days Sales Outstanding69.7764.3763.5352.259.7855.8664.4577.2577.6172.39
Inventory505K000000000
Days Inventory Outstanding0.67---------
Other Current Assets3.26M2.62M00673K10.95M2.19M1.89M2.13M20.87M
Total Non-Current Assets63.65M75.08M106.53M109.2M132.91M151.83M134.72M113.95M127.6M131.82M
Property, Plant & Equipment22.81M18.9M82.31M84.59M106.7M125.03M112.07M89.01M94.84M96.85M
Fixed Asset Turnover14.64x18.11x4.48x4.79x4.16x3.94x4.67x5.71x5.89x6.45x
Goodwill11.83M11.83M11.83M11.83M11.83M11.83M11.83M11.83M11.83M11.83M
Intangible Assets5.97M4.18M2.93M2.78M3.21M700K0000
Long-Term Investments294K392K227K2.94M258K382K000451K
Other Non-Current Assets18.35M34.56M6.71M4.83M6.66M4.61M6.23M8.82M13.76M67.53M
Total Assets
152.23M▲ 0%
157.08M▲ 3.2%
188.3M▲ 19.9%
195.24M▲ 3.7%
274.29M▲ 40.5%
294.18M▲ 7.3%
293.32M▼ 0.3%
293.9M▲ 0.2%
273.21M▼ 7.0%
297.25M▲ 0%
Asset Turnover2.19x2.18x1.96x2.08x1.62x1.68x1.78x1.73x2.04x2.18x
Asset Growth %9.96%3.19%19.88%3.68%40.49%7.25%-0.29%0.2%-7.04%2.39%
Total Current Liabilities99.89M116.23M111.38M105.65M105.72M97.77M73.26M71M79.94M84.8M
Accounts Payable13.69M13.15M9.93M10.35M5.98M20.3M18.7M16.72M18.69M0
Days Payables Outstanding18.0918.9814.2313.686.5119.8218.2117.1217.6919.07
Short-Term Debt43.3M51.18M41.84M40.14M26.72M28.89M413K660K015.41M
Deferred Revenue (Current)4.92M5.66M4.39M3.47M4.08M8.6M6.41M4.75M5.5M27.01M
Other Current Liabilities1M21.9M19.07M18.59M35.83M3.56M00062.55M
Current Ratio0.89x0.71x0.73x0.81x1.34x1.46x2.16x2.53x1.82x1.82x
Quick Ratio0.88x0.71x0.73x0.81x1.34x1.46x2.16x2.53x1.82x1.82x
Cash Conversion Cycle52.34--------53.32
Total Non-Current Liabilities23.61M12.89M68.29M73.43M87.91M82.95M70.1M57.11M58.97M51.67M
Long-Term Debt14.65M9.01M7.18M3.78M1.8M339K600K867K045.61M
Capital Lease Obligations0866K58.6M62.04M71.88M76.32M64.85M53.44M54.6M155.11M
Deferred Tax Liabilities5.34M61.29M147K117K86K00000
Other Non-Current Liabilities1.11M2.31M1.61M7.06M11.14M2.3M3.26M1.67M3.23M17.23M
Total Liabilities123.49M129.13M179.67M179.09M193.63M180.72M143.36M128.1M138.91M136.46M
Total Debt57.95M62.96M118.25M105.97M112.52M105.54M78.9M67.02M69.75M61.02M
Net Debt36.63M49.44M109.38M84.1M54.67M56.71M21.47M4.3M54.41M45.62M
Debt / Equity1.19x1.31x13.71x6.56x1.39x0.93x0.53x0.40x0.52x0.52x
Debt / EBITDA5.04x-4.27x2.41x3.61x2.73x1.33x1.14x1.09x0.80x
Net Debt / EBITDA3.18x-3.95x1.91x1.75x1.46x0.36x0.07x0.85x0.85x
Interest Coverage-0.65x-9.68x0.94x2.01x1.89x16.03x51.92x80.74x29.11x62.30x
Total Equity
48.74M▲ 0%
47.95M▼ 1.6%
8.63M▼ 82.0%
16.15M▲ 87.2%
80.66M▲ 399.5%
113.46M▲ 40.7%
149.96M▲ 32.2%
165.8M▲ 10.6%
134.31M▼ 19.0%
160.78M▲ 0%
Equity Growth %146.81%-1.61%-82.01%87.16%399.5%40.66%32.17%10.56%-18.99%36.27%
Book Value per Share2.752.710.490.914.396.067.949.088.5410.72
Total Shareholders' Equity28.74M27.95M8.63M16.15M80.66M113.46M149.96M165.8M134.31M160.78M
Common Stock1K12K12K12K2K2K2K2K1K2K
Retained Earnings-110.03M-126.06M-117.18M-109.53M-110.68M-76.36M-44.78M-11.12M25.74M63.33M
Treasury Stock00000-3.41M-3.68M-25.37M-103.34M0
Accumulated OCI22.55M37.8M29.59M29.46M33.18M5.79M-6.31M-7.91M-6.34M-13.32M
Minority Interest20M20M00000000

IBEX Cash Flow Statement

IBEX Limited (IBEX) cash flow — operating, investing & free cash flow history

Line itemJun'17Jun'18Jun'19Jun'20Jun'21Jun'22Jun'23Jun'24Jun'25TTM
Cash from Operations6.65M-5.75M2.2M51.72M16.08M40.01M41.86M35.9M45.67M45.67M
Operating CF Margin %1.99%-1.68%0.6%12.77%3.63%8.12%8%7.06%8.18%-
Operating CF Growth %118.47%-186.47%138.32%2248.73%-68.91%148.84%4.63%-14.24%27.21%678.92%
Net Income-8.72M-15.94M19.41M7.77M13.09M21.46M31.58M33.66M36.86M47.18M
Depreciation & Amortization13.83M12.42M21.8M24.47M14.12M18.1M18.98M19.46M17.23M18.55M
Stock-Based Compensation323K8.94M5.26M359K5.36M1.85M4.61M3.77M5.43M946K
Deferred Taxes-1.72M-6.24M-13.44M0-1.91M-5.17M4.53M344K-2.88M-1.96M
Other Non-Cash Items6.39M5.33M13.38M11.51M12.41M15.04M15.85M15.95M15.32M-38.33M
Working Capital Changes-3.46M-10.26M-44.22M7.61M-26.98M-11.27M-33.69M-37.28M-26.3M8.46M
Change in Receivables4.01M758K-18.02M9.04M-13.33M-9.71M-12.3M0-19.26M-9.57M
Change in Inventory0000000000
Change in Payables2.34M4.41M9M0-4.01M2.31M-3.75M-2.25M6.25M8.74M
Cash from Investing-9.75M-5.44M-9.08M-4.83M-20.82M-25.92M-19.04M-8.86M-18.38M-29.8M
Capital Expenditures-9.93M-5.76M-6.23M-4.28M-20.82M-25.92M-18.95M-8.86M-18.38M-29.8M
CapEx % of Revenue2.97%1.68%1.69%1.06%4.7%5.26%3.62%1.74%3.29%-
Acquisitions177K182K-3.04M000-85K000
Investments----------
Other Investing177K715K810K-552K000000
Cash from Financing14.98M3.19M2.55M-33.87M40.9M-22.13M-13.61M-21.73M-74.66M-29.69M
Debt Issued (Net)15.76M3.33M10.12M-19.2M-17.16M-18.76M-15.39M-543K-953K-19.96M
Equity Issued (Net)25K0-5.97M063.11M-3.41M-276K-21.56M-78.01M-7.15M
Dividends Paid-1M-146K-1.6M0-4M00000
Share Repurchases00-5.97M00-3.41M-276K-21.56M-78.01M-1.59M
Other Financing190K00-14.67M-1.05M35K2.05M366K4.31M-2.58M
Net Change in Cash
11.87M▲ 0%
-7.8M▼ 165.7%
-4.65M▲ 40.5%
13M▲ 379.7%
35.97M▲ 176.8%
-9.01M▼ 125.1%
8.6M▲ 195.4%
5.29M▼ 38.5%
-47.37M▼ 995.3%
2.43M▲ 0%
Free Cash Flow
-3.29M▲ 0%
-11.51M▼ 250.4%
-4.03M▲ 65.0%
47.44M▲ 1276.5%
-4.75M▼ 110.0%
14.09M▲ 396.8%
22.91M▲ 62.6%
27.05M▲ 18.1%
27.29M▲ 0.9%
32.31M▲ 0%
FCF Margin %-0.98%-3.36%-1.09%11.71%-1.07%2.86%4.38%5.32%4.89%5.15%
FCF Growth %58.09%-250.44%64.98%1276.49%-110.01%396.82%62.61%18.06%0.92%63.88%
FCF per Share-0.19-0.65-0.232.68-0.260.751.211.481.741.74
FCF Conversion (FCF/Net Income)-0.74x0.36x-0.49x6.66x1.23x1.86x1.33x1.07x1.24x0.68x
Interest Paid0009.43M01.25M152K514K1.63M913K
Taxes Paid000002.16M4.28M7.69M11.95M-2.78M

IBEX Key Ratios

IBEX Limited (IBEX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)-26.32%-32.85%-15.97%62.72%27.04%22.11%23.98%21.32%24.57%31.81%
Return on Invested Capital (ROIC)-2.26%-14.59%4.74%13.41%10.85%10.13%17.77%17.32%19.49%19.49%
Gross Margin17.32%26.09%30.89%31.81%24.39%24.12%28.32%29.89%30.91%21.33%
Net Margin-2.7%-4.64%-1.23%1.92%2.95%4.35%6.04%6.62%6.6%7.53%
Debt / Equity1.19x1.31x13.71x6.56x1.39x0.93x0.53x0.40x0.52x0.52x
Interest Coverage-0.65x-9.68x0.94x2.01x1.89x16.03x51.92x80.74x29.11x62.30x
FCF Conversion-0.74x0.36x-0.49x6.66x1.23x1.86x1.33x1.07x1.24x0.68x
Revenue Growth3.41%2.44%7.65%9.98%9.44%11.16%6.14%-2.78%9.77%17.04%

IBEX SEC Filings & Documents

IBEX Limited (IBEX) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 6, 2026·SEC

Material company update

Feb 5, 2026·SEC

Material company update

Dec 19, 2025·SEC

10-K Annual Reports

3
FY 2025

Sep 11, 2025·SEC

FY 2024

Sep 12, 2024·SEC

FY 2023

Sep 13, 2023·SEC

10-Q Quarterly Reports

6
FY 2026

May 6, 2026·SEC

FY 2026

Feb 5, 2026·SEC

FY 2025

Nov 6, 2025·SEC

IBEX Frequently Asked Questions

IBEX Limited (IBEX) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

IBEX Limited (IBEX) reported $626.9M in revenue for fiscal year 2025. This represents a 94% increase from $323.0M in 2016.

IBEX Limited (IBEX) grew revenue by 9.8% over the past year. This is steady growth.

Yes, IBEX Limited (IBEX) is profitable, generating $47.2M in net income for fiscal year 2025 (6.6% net margin).

Dividend & Returns

IBEX Limited (IBEX) has a return on equity (ROE) of 24.6%. This is excellent, indicating efficient use of shareholder capital.

IBEX Limited (IBEX) generated $32.3M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More IBEX

IBEX Limited (IBEX) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.